Sulforaphane has been associated with the modulation of Nrf2/Keap and NF-κB, contributing to protection against cardiovascular-related inflammation, atherosclerosis, hypertension, diabetes mellitus, cardiomyopathy, and heart failure [12]. Here, NFE2L2 is linked to cardiomyopathy.